The Nigeria Centre for Disease Control and Prevention (NCDC) confirmed that 34 out of 62 traced contacts linked to Nigeria’s index imported Ebola case have successfully completed their mandatory 21-day surveillance period without developing symptoms, while 28 contacts remain under active monitoring. ​
Speaking during an official press briefing in Abuja, NCDC Director-General Dr. Jide Idris announced that Nigeria has recorded no additional confirmed cases of the virus since the initial index case was diagnosed three weeks ago.
A female traveller who arrived in Nigeria on an international flight from Uganda was admitted to a private hospital in the Federal Capital Territory (FCT), Abuja, where she tested positive for the Bundibugyo strain of the Ebola virus.
She was subsequently evacuated to Switzerland for specialized medical care. Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, previously outlined the containment protocols activated immediately following the confirmation in Abuja. 62 total primary contacts were identified across healthcare workers, flight personnel, and community contacts.
As of November 11, 2026, 34 individuals completed their individual 21-day follow-ups between October 31 and November 9, 2026. The remaining 28 contacts are scheduled to complete their monitoring window by November 13, 2026. ​Dr. Idris clarified that placement under monitoring does not indicate infection, but serves as a preventive precaution to ensure rapid intervention should symptoms arise.
​”Our priorities remain contact tracing, prompt investigation of alerts, laboratory testing, infection prevention, safe clinical care, and heightened surveillance at point-of-entry borders,” stated Dr. Idris. “A person identified as a contact does not necessarily have Ebola. Follow-up enables health teams to identify symptoms early and respond safely.” ​
With the upcoming end-of-year festive travel season, the NCDC advised members of the public, event organisers, and healthcare providers to maintain strict hygiene standards and report any unexplained fever, rash, or body weakness via the NCDC national toll-free line at 6232.
